Literature DB >> 3276418

Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis.

L H Noël1, P Aucouturier, R C Monteiro, J L Preud'Homme, P Lesavre.   

Abstract

The distribution of human IgG subclasses among the glomerular deposits of 53 patients with glomerulonephritis was examined by immunofluorescence (IF) with subclass-specific monoclonal antibodies (Mab). A subclass restriction was observed in idiopathic membranous nephropathy (MN) with glomerular deposits predominantly containing IgG4 (81% of the studied biopsies) and IgG1 (75%). In de novo MN, occurring after transplantation, the restriction was markedly different, with a predominance of IgG1 (100%) and IgG2 (69%). In anti-glomerular basement membrane (a-GBM) nephritis the restriction was considerable with deposits containing almost exclusively IgG1 (91%) and IgG4 (73%). The same restriction was observed for circulating anti-GBM antibodies detected by indirect IF assay. By contrast IgG1, IgG2, and IgG3 deposits were identified in lupus proliferative glomerulonephritis. Serum IgG subclass levels were measured in 29 patients with idiopathic MN and a-GBM nephritis by an indirect competitive immunoenzymatic assay using Mab. Mean percentage of IgG2 serum level was significantly lower in patients. In spite of high variations from patient to patient, a serum IgG subclass imbalance was clearly present in 10 cases with low IgG2 and high IgG1 and IgG3 levels. The imbalance in these patients was not due to urinary loss since it was observed with a similar frequency in hypo- and normoimmunoglobulinemic patients. In 5 out of these 10 patients IgG2 levels were very low, analogous to those observed in selective IgG2 deficiency. Whether the important subclass restriction of glomerular IgG (in which patterns differed according to the type of glomerulonephritis) and the serum subclass imbalances were due to a clonally restricted antibody response to a particular antigen or to a host immune response defect, or both, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276418     DOI: 10.1016/0090-1229(88)90181-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  17 in total

1.  Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.

Authors:  Angela Giorgini; Heather J Brown; Helen R Lock; Falk Nimmerjahn; Jeffrey V Ravetch; J Sjef Verbeek; Steven H Sacks; Michael G Robson
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up.

Authors:  V L Esnault; D R Jayne; A P Weetman; C M Lockwood
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.

Authors:  Carmen Lefaucheur; Denis Viglietti; Carol Bentlejewski; Jean-Paul Duong van Huyen; Dewi Vernerey; Olivier Aubert; Jérôme Verine; Xavier Jouven; Christophe Legendre; Denis Glotz; Alexandre Loupy; Adriana Zeevi
Journal:  J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 10.121

Review 4.  Basement membranes and autoimmune diseases.

Authors:  Mary H Foster
Journal:  Matrix Biol       Date:  2016-08-02       Impact factor: 11.583

Review 5.  Th1 and Th2 cells in autoimmunity.

Authors:  P Druet; R Sheela; L Pelletier
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

6.  IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis.

Authors:  D R Jayne; A P Weetman; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

Review 7.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

8.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

9.  CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

Authors:  Paul Gutwein; Mohamed Sadek Abdel-Bakky; Anja Schramme; Kai Doberstein; Nicole Kämpfer-Kolb; Kerstin Amann; Ingeborg A Hauser; Nicholas Obermüller; Christine Bartel; Abdel-Aziz H Abdel-Aziz; El Sayed M El Sayed; Josef Pfeilschifter
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

10.  Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library.

Authors:  Fabrizio Cavazzini; Riccardo Magistroni; Luciana Furci; Valentina Lupo; Giulia Ligabue; Maria Granito; Marco Leonelli; Alberto Albertazzi; Gianni Cappelli
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.